CCND1 1722 polymorphism and potential relevance to upper tract urothelial cancer

Anticancer Research

Volumn 31, Issue 3, 2011, Pages 1043-1047

  Lin, Hui Hui ^a   Ke, Hung Lung ^a,b   Hsiao, Kuang Hung ^a   Tsai, Chia Wen ^c   Wu, Wen Jeng ^b,d   Bau, Da Tian ^c,e   Chang, Lin Li ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

CCND1 1722; Cyclin D1; Polymorphism; Upper tract urothelial cancer

Indexed keywords

CYCLIN D1;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TUMOR RECURRENCE; URETER TUMOR; UROGENITAL TRACT CANCER;

AGED; CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 79956138093     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Carroll P: Urothelial carcinoma: cancers of bladder, ureter and renal pelvis. In: General Urology, 14th ed. Tanagho EA and McAninch JW (eds.). Philadelphia: Prentice-Hall Int, pp. 353-371, 1995.
2. Mahony JF, Storey BG, Ibanez RC and Stewart JH: Analgesic abuse, renal parenchymal disease and carcinoma of the kidney or ureter. Aust NZ J Med 7: 463-469, 1977. (Pubitemid 8238058)
3. Mellemgaard A, Carstensen B, Norgaard N, Knudsen JB and Olsen JH: Trends in the incidence of cancer of the kidney, pelvis, ureter and bladder in Denmark 1943-88. Scand J Urol Nephrol 27: 327-332, 1993.
4. McLaughlin JK, Silverman DT, Hsing AW, Ross RK, Schoenberg JB, Yu MC, Stemhagen A, Lynch CF, Blot WJ and Fraumeni JF Jr.: Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 52: 254-257, 1992.
5. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, Kuo TL and Tai TY: Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25: 53-60, 1995.
6. Linet MS, Chow WH, McLaughlin JK, Wacholder S, Yu MC, Schoenberg JB, Lynch C and Fraumeni JF Jr.: Analgesics and cancers of the renal pelvis and ureter. Int J Cancer 62: 15-18, 1995.
7. Liaw KL, Linet MS, McLaughlin JK, Yu MC, Schoenberg JB, Lynch CF, Niwa S and Fraumeni JF Jr.: Possible relation between hypertension and cancers of the renal pelvis and ureter. Int J Cancer 70: 265-268, 1997. (Pubitemid 27099592)
8. Reznikoff CA, Sarkar S, Julicher KP, Burger MS, Puthenveettil JA, Jarrard DF and Newton MA: Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol 5: 191-203, 2000.
9. Suwa Y, Takano Y, Iki M, Takeda M, Asakura T, Noguchi S and Masuda M: Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder. J Urol 160: 897-900, 1998. (Pubitemid 29479551)
10. Sgambato A, Migaldi M, Faraglia B, De Aloysio G, Ferrari P, Ardito R, De Gaetani C, Capelli G, Cittadini A and Trentini GP: Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome. Int J Cancer 97: 671-678, 2002. (Pubitemid 34087809)
11. Yang CH, Hung WC, Wang SL, Kang WY, Chen WT, Huang YC, Su YC and Chai CY: Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma. APMIS 116: 309-316, 2008.
12. Lee CC, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, Nakatani T, Wada S, Kishimoto T and Fukushima S: Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 79: 780-789, 1997. (Pubitemid 27076344)
13. Shin KY, Kong G, Kim WS, Lee TY, Woo YN and Lee JD: Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. Br J Cancer 75: 1788-1792, 1997. (Pubitemid 27230705)
14. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD and Heighway J: Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11: 1005-1011, 1995.
15. Cortessis VK, Siegmund K, Xue S, Ross RK and Yu MC: A case-control study of cyclin D1 CCND1 870A - >G polymorphism and bladder cancer. Carcinogenesis 24: 1645-1650, 2003.
16. Ito M, Habuchi T, Watanabe J, Higashi S, Nishiyama H, Wang L, Tsuchiya N, Kamoto T and Ogawa O: Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer. Urology 64: 74-78, 2004. (Pubitemid 38887582)
17. Knudsen KE, Diehl JA, Haiman CA and Knudsen ES: Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25: 1620-1628, 2006.
18. Wang L, Habuchi T, Takahashi T, Mitsumori K, Kamoto T, Kakehi Y, Kakinuma H, Sato K, Nakamura A, Ogawa O and Kato T: Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23: 257-264, 2002.
19. Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R and Miller AB: Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 44: 622-628, 1989.
20. Rogers S, Wells R and Rechsteiner M: Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368, 1986. (Pubitemid 17181385)
21. Heighway J: HaeIII polymorphism within 3' untranslated region of PRAD1. Nucleic Acids Res 19: 5451, 1991.
22. Holley SL, Parkes G, Matthias C, Bockmuhl U, Jahnke V, Leder K, Strange RC, Fryer AA and Hoban PR: Cyclin D1 polymorphism and expression in patients with squamous cell Carcinoma of the head and neck. Am J Pathol 159: 1917-1924, 2001.
23. Greene FL, Page DL and Fleming ID: AJCC Cancer Staging Manual, 6th edition. New York: Springer-Verlag, pp. 45-88, 2002.
24. Epstein JI, Amin MB, Reuter VR and Mostofi FK: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22: 1435-1448, 1998. (Pubitemid 28550639)
25. Chang LL, Yeh WT, Yang SY, Wu WJ and Huang CH: Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer. J Urol 170: 595-600, 2003.
26. Wang HC, Chang WS, Tsai RY, Tsai CW, Liu LC, Su CH, Cheng HN, Tsou YA, Sun SS, Lin CC and Bau DT. Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females. Anticancer Res 30: 5217-5221, 2010.
27. Tsou YA, Hua CH, Tseng HC, Hsu CF, Tsai CW, Sun SS, Tsai RY, Tsai MH and Bau DT. The joint effect of hOGG1 single nucleotide polymorphism and betel quid chewing on oral cancer in Taiwan. Anticancer Res 30: 4205-4208, 2010.
28. Wu HC, Chang CH, Tsai RY, Lin CH, Wang RF, Tsai CW, Chen KB, Yao CH, Chiu CF, Bau DT and Lin CC. Significant association of methylenetetrahydroofolate reductase single nucleotide polymorphisms with prostate cancer susceptibility in Taiwan. Anticancer Res 30: 3573-3577, 2010.
29. Bau DT, Yang MD, Tsou YA, Lin SS, Wu CN, Hsieh HH, Wang RF, Tsai CW, Chang WS, Hsieh HM, Sun SS and Tsai RY. Colorectal cancer and genetic polymorphism of DNA double-strand break repair gene XRCC4 in Taiwan. Anticancer Res 30: 2727-2730, 2010.
30. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
31. Kirkali Z and Tuzel E: Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47: 155-169, 2003. (Pubitemid 36945314)
32. Lipworth L, Tarone RE and McLaughlin JK: The epidemiology of renal cell carcinoma. J Urol 176: 2353-2358, 2006.
33. Chen CJ, Chuang YC, You SL, Lin TM and Wu HY: A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53: 399-405, 1986.
34. Chen CJ, Chuang YC, Lin TM and Wu HY: Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 45: 5895-5899, 1985.